Singapore O&G 주식 주식분석 | 주식가격 | 뉴스 | 1D8.SI | SG1DG2000005 |

날짜	Singapore O&G 주식 가격
	0.28 SGD
	0.28 SGD

날짜	Singapore O&G 매출	Singapore O&G EBIT	Singapore O&G 이익
2023e	39.95 백만 SGD	0 SGD	0 SGD
2022e	40.64 백만 SGD	0 SGD	0 SGD
2021	42.4 백만 SGD	9.84 백만 SGD	8.36 백만 SGD
2020	39.89 백만 SGD	9.89 백만 SGD	9.49 백만 SGD
2019	39.76 백만 SGD	12.47 백만 SGD	-1.13 백만 SGD
2018	34.68 백만 SGD	12.4 백만 SGD	9.15 백만 SGD
2017	29.9 백만 SGD	9.87 백만 SGD	8.51 백만 SGD
2016	28.67 백만 SGD	10.4 백만 SGD	8.8 백만 SGD
2015	16.41 백만 SGD	6.16 백만 SGD	5.34 백만 SGD
2014	13.55 백만 SGD	5.04 백만 SGD	4.25 백만 SGD
2013	8.64 백만 SGD	3.73 백만 SGD	3.12 백만 SGD
2012	8.12 백만 SGD	3.43 백만 SGD	3 백만 SGD

	매출	EBIT	이익
2012	8.12 백만 SGD	3.43 백만 SGD	3 백만 SGD
2013	8.64 백만 SGD	3.73 백만 SGD	3.12 백만 SGD
2014	13.55 백만 SGD	5.04 백만 SGD	4.25 백만 SGD
2015	16.41 백만 SGD	6.16 백만 SGD	5.34 백만 SGD
2016	28.67 백만 SGD	10.4 백만 SGD	8.8 백만 SGD
2017	29.9 백만 SGD	9.87 백만 SGD	8.51 백만 SGD
2018	34.68 백만 SGD	12.4 백만 SGD	9.15 백만 SGD
2019	39.76 백만 SGD	12.47 백만 SGD	-1.13 백만 SGD
2020	39.89 백만 SGD	9.89 백만 SGD	9.49 백만 SGD
2021	42.4 백만 SGD	9.84 백만 SGD	8.36 백만 SGD
2022e	40.64 백만 SGD	0 SGD	0 SGD
2023e	39.95 백만 SGD	0 SGD	0 SGD

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022e	2023e
8	8	13	16	28	29	34	39	39	42	40	39
-	-	62.50	23.08	75.00	3.57	17.24	14.71	-	7.69	-4.76	-2.50
75.00	87.50	92.31	87.50	85.71	86.21	85.29	84.62	84.62	83.33	87.50	89.74
6	7	12	14	24	25	29	33	33	35	0	0
3	3	4	5	8	8	9	-1	9	8	0	0
-	-	33.33	25.00	60.00	-	12.50	-111.11	-1,000.00	-11.11	-	-
-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-
348.8	348.8	348.8	399.67	471.7	476.8	476.8	476.8	477	476.8	0	0
-	-	-	-	-	-	-	-	-	-	-	-

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021

4.58	24.21	21.38	0	21.38	16.43	21.55	25.98	35.51	35.77
0.42	1.1	1.34	0	1.34	1.47	1.88	2.22	2.4	2.02
250	86.62	86.7	0	86.7	23.51	440	530	430	530
0.16	0.28	2.15	0	2.15	1.6	1.66	2.03	1.91	2.13
0.14	0.57	0.57	0.15	0.67	1.02	0.66	0.77	0.72	0.75
5.55	26.24	25.52	0.15	25.62	20.55	26.19	31.53	40.97	41.2
0.31	0.68	1.55	0	1.55	1.64	1.41	5.29	4.65	3.9
0	0	0	148.41	148.41	0	0	0	0	460
0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	20	20	0	0
0	0.84	26.93	0	26.93	26.93	24.13	12.23	12.23	12.23
0	0	10.45	0	10.45	12.02	0	0	0	0
0.31	1.52	28.5	0.15	28.64	28.58	25.56	17.54	16.88	16.59
5.86	27.76	54.02	0.29	54.27	49.13	51.75	49.07	57.85	57.79

0	14.43	29.65	0	29.65	29.65	29.65	29.65	29.81	29.99
0	0	0	0	0	0	0	0	0	0
4.87	9.58	12	0	12	13.85	14.94	6.56	13.7	13.21
0	0	0	0	0	0	0	0	0	-0.01
0	0	0	0	0	0	0	0	0	0
4.87	24.01	41.64	0	41.64	43.5	44.59	36.21	43.51	43.19
0.1	0.53	0.53	0	0.84	0.64	0.85	1.26	1.55	1.07
0.09	0.58	0.58	0	1.81	2.49	3.15	4.38	7.12	8.43
0.68	2.38	6.14	0	6.14	2.38	2.99	3.27	2.72	2.77
0	0	0	0	0	0	0	0	0	0
0.04	0	0	0	0	0	0	1.43	1.48	1.56
0.91	3.49	7.25	0	8.79	5.52	6.99	10.34	12.87	13.83
0.05	0	0	0	0	0	0	2.38	1.83	1.1
20	85.54	66.6	0	66.6	109.83	140	130	120	130
0	0	0	0	3.76	0	0	0	0	0
0.07	0.09	0.07	0	3.83	0.11	0.14	2.51	1.95	1.23
0.98	3.57	7.31	0	12.62	5.63	7.13	12.85	14.82	15.06
5.85	27.59	48.96	0	54.27	49.13	51.72	49.06	58.33	58.25

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021
3	3	5	6	10	9	10	0	10	9
0	0	0	0	0	0	0	2	2	2
0	0	0	0	0	0	0	0	0	0
-1,000	0	0	0	0	-8,000	0	0	1,000	0
0	0	0	0	0	0	2	12	0	0
0	0	0	0	0	0	0	0	0	0
0	0	0	0	1,000	1,000	1,000	1,000	1,000	1,000
2	3	4	6	10	2	13	14	14	11
0	0	0	0	0	0	0	0	0	0
0	0	2	0	-6	0	0	0	0	-1
0	0	2	0	-5	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	-1	-1	-1
0	0	0	10	0	0	0	0	0	0
0	-1	-2	6	-6	-6	-8	-8	-4	-10
-	-	-	-	-	-	-	-	-	-
0	-1	-2	-3	-6	-6	-8	-7	-2	-8
1	1	4	12	-2	-4	5	4	9	0
0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0

Singapore O&G 브루토마진	Singapore O&G 이익 마진	Singapore O&G EBIT-마진	Singapore O&G 이익 마진
2023e	82.62 %	0 %	0 %
2022e	82.62 %	0 %	0 %
2021	82.62 %	23.21 %	19.72 %
2020	83.18 %	24.79 %	23.79 %
2019	83.73 %	31.36 %	-2.84 %
2018	85.96 %	35.76 %	26.38 %
2017	84.74 %	33.01 %	28.45 %
2016	84.77 %	36.26 %	30.7 %
2015	88.68 %	37.52 %	32.54 %
2014	88.85 %	37.21 %	31.36 %
2013	86 %	43.17 %	36.11 %
2012	84.48 %	42.24 %	36.95 %

	브루토마진	EBIT-마진	이익 마진
2012	84.48 %	42.24 %	36.95 %
2013	86 %	43.17 %	36.11 %
2014	88.85 %	37.21 %	31.36 %
2015	88.68 %	37.52 %	32.54 %
2016	84.77 %	36.26 %	30.7 %
2017	84.74 %	33.01 %	28.45 %
2018	85.96 %	35.76 %	26.38 %
2019	83.73 %	31.36 %	-2.84 %
2020	83.18 %	24.79 %	23.79 %
2021	82.62 %	23.21 %	19.72 %
2022e	82.62 %	0 %	0 %
2023e	82.62 %	0 %	0 %

날짜	Singapore O&G 주당 매출	Singapore O&G EBIT 당 주식	Singapore O&G 주당 이익
2023e	0.08 SGD	0 SGD	0 SGD
2022e	0.08 SGD	0 SGD	0 SGD
2021	0.09 SGD	0.02 SGD	0.02 SGD
2020	0.08 SGD	0.02 SGD	0.02 SGD
2019	0.08 SGD	0.03 SGD	-0 SGD
2018	0.07 SGD	0.03 SGD	0.02 SGD
2017	0.06 SGD	0.02 SGD	0.02 SGD
2016	0.06 SGD	0.02 SGD	0.02 SGD
2015	0.04 SGD	0.02 SGD	0.01 SGD
2014	0.04 SGD	0.01 SGD	0.01 SGD
2013	0.02 SGD	0.01 SGD	0.01 SGD
2012	0.02 SGD	0.01 SGD	0.01 SGD

	주당 매출	EBIT 당 주식	주당 이익
2012	0.02 SGD	0.01 SGD	0.01 SGD
2013	0.02 SGD	0.01 SGD	0.01 SGD
2014	0.04 SGD	0.01 SGD	0.01 SGD
2015	0.04 SGD	0.02 SGD	0.01 SGD
2016	0.06 SGD	0.02 SGD	0.02 SGD
2017	0.06 SGD	0.02 SGD	0.02 SGD
2018	0.07 SGD	0.03 SGD	0.02 SGD
2019	0.08 SGD	0.03 SGD	-0 SGD
2020	0.08 SGD	0.02 SGD	0.02 SGD
2021	0.09 SGD	0.02 SGD	0.02 SGD
2022e	0.08 SGD	0 SGD	0 SGD
2023e	0.08 SGD	0 SGD	0 SGD

	주식 수량
2012	348.8 백만 Aktien
2013	348.8 백만 Aktien
2014	348.8 백만 Aktien
2015	399.67 백만 Aktien
2016	471.7 백만 Aktien
2017	476.8 백만 Aktien
2018	476.8 백만 Aktien
2019	476.8 백만 Aktien
2020	477 백만 Aktien
2021	476.8 백만 Aktien
2022e	476.8 백만 Aktien
2023e	476.8 백만 Aktien

날짜	Singapore O&G 배당률
2023e	67.85 %
2022e	72.9 %
2021	105.51 %
2020	25.13 %
2019	-641.36 %
2018	88.06 %
2017	78.19 %
2016	71.8 %
2015	32.92 %
2014	72.9 %
2013	72.9 %
2012	72.9 %

	배당률
2012	72.9 %
2013	72.9 %
2014	72.9 %
2015	32.92 %
2016	71.8 %
2017	78.19 %
2018	88.06 %
2019	-641.36 %
2020	25.13 %
2021	105.51 %
2022e	72.9 %
2023e	67.85 %

%-지분	이름	주식	변경
15.77143 %	Lee (Keen Whye)	75,600,356	-6,104,524
10.43079 %	NewMedCo Group Ltd.	50,000,000	50,000,000
7.28054 %	Choo (Wan Ling)	34,899,278	0
1.27350 %	Wong (Chui Fong)	6,104,524	6,104,524
0.56574 %	Heng (Tong Bwee)	2,711,886	110,000
0.44164 %	VSTL Investment Ltd.	2,117,000	0
0.36684 %	Chua (Weilyn Natalie)	1,758,466	333,333
0.36021 %	Pang (Yi Ping Cindy)	1,726,666	333,333
0.32335 %	Yeo (Wei Huang)	1,550,000	-150,000
0.31292 %	STF Investments Ltd.	1,500,000	0
0.28973 %	Ang (Hao Yao)	1,388,800	-719,200
0.24222 %	IFast Financial Pte Ltd.	1,161,100	-163,700
0.09847 %	Beh (Suan Tiong)	472,000	-48,008,452
0.07302 %	Choo (Kok Wei Eric)	350,000	350,000
0 %	Heng (Tung Lan)	0	-140,453,614
0 %	Lim (Teng Ee Joyce)	0	-41,053,002

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
DBS Group Holdings	공급업체고객	0,37	0,38	-0,35	-0,37	0,30
Citigroup	공급업체고객	0,16	0,26	-0,53	-0,70	-0,75

What values and corporate philosophy does Singapore O&G represent?

Singapore O&G Ltd is committed to delivering quality healthcare services to women and children. With a patient-centric approach, the company prioritizes the well-being and satisfaction of its patients. Singapore O&G Ltd upholds a corporate philosophy centered around professionalism, integrity, and compassion. By employing a team of highly skilled medical professionals and investing in cutting-edge technology, the company strives to provide top-notch medical care. Singapore O&G Ltd also places great importance on continuous learning and innovation, ensuring that it remains at the forefront of medical advancements. Through its values of excellence, trust, and empathy, Singapore O&G Ltd aims to be a trusted and preferred healthcare provider for women and children in Singapore and beyond.

In which countries and regions is Singapore O&G primarily present?

Singapore O&G Ltd is primarily present in Singapore.

What significant milestones has the company Singapore O&G achieved?

Singapore O&G Ltd has accomplished several notable milestones. Firstly, the company successfully listed on Singapore Exchange Securities Trading Limited in 2015, a significant achievement that boosted its market presence. Furthermore, Singapore O&G Ltd expanded its operations by acquiring four specialist clinics specializing in obstetrics and gynecology and medical aesthetics. Additionally, the company established collaborations with reputable medical institutions and universities, enhancing its expertise and credibility within the healthcare industry. With a strong emphasis on delivering high-quality healthcare services to patients, Singapore O&G Ltd continues to solidify its position as a leading and trusted provider in the field.

What is the history and background of the company Singapore O&G?

Singapore O&G Ltd is a prominent healthcare company headquartered in Singapore. Established in 2011, the company specializes in women's healthcare and provides a comprehensive range of medical services for obstetrics, gynecology, and urogynecology. With a team of highly skilled and experienced specialists, Singapore O&G aims to deliver exceptional patient care and outcomes. The company operates multiple clinics across Singapore, offering easy accessibility to its services. Over the years, Singapore O&G has gained a strong reputation for its expertise, patient-centric approach, and commitment to medical innovation. It continues to contribute significantly to the advancement of women's healthcare in Singapore.

Who are the main competitors of Singapore O&G in the market?

The main competitors of Singapore O&G Ltd in the market include other major healthcare providers and medical service companies that operate in Singapore. Notable competitors of Singapore O&G Ltd in the industry include Raffles Medical Group, Health Management International Ltd, and Q&M Dental Group. These companies also provide a range of medical services and specialties, catering to the healthcare needs of the local population. Singapore O&G Ltd competes with these firms in terms of service quality, medical expertise, and market share.

In which industries is Singapore O&G primarily active?

Singapore O&G Ltd is primarily active in the healthcare industry, specializing in women's and children's medical services. With a focus on obstetrics and gynaecology, paediatrics, and dermatology, Singapore O&G Ltd offers a comprehensive range of healthcare solutions. As a leading provider in Singapore, the company has established a strong reputation for its expertise and quality care in these specific areas. The healthcare expertise of Singapore O&G Ltd extends to various specialties within women's and children's health, making it a trusted choice for patients seeking specialized medical attention in these fields.

What is the business model of Singapore O&G?

The business model of Singapore O&G Ltd revolves around providing specialized healthcare services for women and children in Singapore and the region. Offering comprehensive and quality medical care, Singapore O&G Ltd operates through a multi-disciplinary approach with a team of experienced doctors and specialists. Their services encompass obstetrics and gynecology, cancer screening, fertility treatment, pediatric care, and dermatology, among others. With a patient-centric approach, Singapore O&G Ltd aims to deliver personalized healthcare solutions, employing advanced medical technologies and innovative treatments. Through its dedicated and skilled team, the company strives to enhance the well-being and quality of life for women and children, making Singapore O&G Ltd a leading healthcare provider in the industry.

Singapore O&G 2025의 P/E 비율은 얼마입니까?

Singapore O&G에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Singapore O&G 2025의 KUV는 얼마입니까?

Singapore O&G에 대한 현재 KUV는 계산할 수 없습니다.

Singapore O&G의 AlleAktien 품질 점수는 얼마인가요?

Singapore O&G에 대한 AlleAktien 품질 점수는 5/10입니다.

Singapore O&G 2025의 매출은 얼마인가요?

Singapore O&G에 대한 현재 매출은 계산할 수 없습니다.

Singapore O&G 2025의 이익은 얼마인가요?

Singapore O&G의 현재 이익을 계산할 수 없습니다.

Singapore O&G은 무엇을 하나요?

Singapore O&G Ltd is a company that specializes in medical services and is headquartered in Singapore. The company's business model focuses on various specialized medical areas, including gynecology, obstetrics, pediatrics, urology, dermatology, ophthalmology, and gastroenterology. Singapore O&G Ltd provides specialized services such as pregnancy care, prenatal diagnostics, fertility treatment, cancer screening, and menopause management in the gynecology and obstetrics field. In the pediatrics field, the company offers services including vaccinations, development care, preventive examinations, and neonatology. In urology, the company provides treatments for diseases such as prostate cancer, urinary incontinence, kidney stones, and erectile dysfunction. In dermatology, the company focuses on the treatment of skin diseases such as acne, psoriasis, eczema, and skin cancer. In ophthalmology, Singapore O&G Ltd offers services such as eye examinations, glaucoma treatment, cataract surgery, and laser eye correction. In the gastroenterology field, the company provides endoscopy services and treatments for digestive system diseases such as gastric ulcers, colorectal cancer, and irritable bowel syndrome. In addition to these services, the company also sells medical products and its own products, including maternity underwear, dietary supplements, and cosmetics. Singapore O&G Ltd operates multiple clinics in Singapore and employs over 30 doctors and specialists in their respective fields. The company focuses on high patient satisfaction and invests in modern medical equipment and technology. They also have a comprehensive online presence with information about the various specialized areas and services, as well as the ability to schedule appointments online. Through a clear focus on specialized medical areas and high-quality services, Singapore O&G Ltd has established itself as a leading medical institution in Singapore. The company's business model is designed to prioritize customer satisfaction, diversify its specialized areas, sell its own products and services, and embrace technological advancements. The company aims to offer a wide range of medical services and further expand its position in the market.